|
Volumn 43, Issue 8, 2002, Pages 1573-1580
|
T-cell rich B-cell lymphoma: Clinical distinctiveness and response to treatment in 45 patients
a b a a b |
Author keywords
Clinical features; Hodgkin's disease; Non Hodgkin's lymphoma; Response to treatment; T cell rich B cell lymphoma
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
B CELL LYMPHOMA;
CANCER CENTER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HODGKIN DISEASE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LYMPH NODE METASTASIS;
MALE;
MEDIASTINUM METASTASIS;
MESENTERY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SALVAGE THERAPY;
SCHOOL CHILD;
SPLEEN INJURY;
SPLENOMEGALY;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TREATMENT OUTCOME;
UNITED STATES;
CHILD;
MIDDLE AGED;
MIXED CELL LYMPHOMA;
MORTALITY;
T CELL LYMPHOMA;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CHILD;
FEMALE;
HUMAN;
LYMPHOMA, B-CELL;
LYMPHOMA, MIXED-CELL, DIFFUSE;
LYMPHOMA, T-CELL;
MALE;
MIDDLE AGE;
SUPPORT, NON-U.S. GOV'T;
HUMANS;
MIDDLE AGED;
|
EID: 0036020960
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/1042819021000002893 Document Type: Article |
Times cited : (7)
|
References (38)
|